Farallon Capital Management Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$17.54B
Q ending 2026-03-31
Prior quarter
$883.7M
Q ending 2025-12-31
Change
+1885.2% QoQ · +6305.6% YoY
Positions
172
reported holdings
Largest positions
Top 100 of 172 reported positions by value, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| State Str Spdr S&P 500 Etf T | Put | $1.50B | 2.3M | |
| Revolution Medicines Inc | RVMD | Shares | $1.32B | 13.6M |
| Amazon Com Inc | AMZN | Shares | $878.6M | 4.2M |
| Microsoft Corp | MSFT | Shares | $868.0M | 2.3M |
| Aon Plc | Shares | $811.0M | 2.5M | |
| Bridgebio Pharma Inc | BBIO | Shares | $695.5M | 9.4M |
| Invesco Exchange Traded Fd T | Put | $690.9M | 3.6M | |
| Protagonist Therapeutics Inc | PTGX | Shares | $669.2M | 6.3M |
| Natera Inc | NTRA | Shares | $641.4M | 3.2M |
| Exelixis Inc | EXEL | Shares | $562.3M | 13.1M |
| Broadcom Inc | AVGO | Shares | $550.8M | 1.8M |
| Unitedhealth Group Inc | UNH | Shares | $492.9M | 1.8M |
| Synopsys Inc | SNPS | Shares | $481.0M | 1.2M |
| Boston Scientific Corp | BSX | Shares | $468.8M | 7.5M |
| Thermo Fisher Scientific Inc | TMO | Shares | $433.3M | 881K |
| Kkr & Co Inc | KKR | Shares | $432.1M | 4.7M |
| Lantheus Hldgs Inc | LNTH | Shares | $423.5M | 5.6M |
| Wabtec | WAB | Shares | $402.2M | 1.6M |
| Schwab Charles Corp | SCHW | Shares | $371.8M | 4.0M |
| Liquidia Corporation | LQDA | Shares | $326.7M | 8.7M |
| Crinetics Pharmaceuticals In | CRNX | Shares | $302.8M | 8.3M |
| Alphabet Inc | GOOG | Shares | $285.8M | 996K |
| Roivant Sciences Ltd | Shares | $268.0M | 9.7M | |
| Visa Inc | V | Shares | $254.1M | 841K |
| Aramark | ARMK | Shares | $248.7M | 6.1M |
| Beam Therapeutics Inc | BEAM | Shares | $241.5M | 10.1M |
| Disney Walt Co | DIS | Shares | $231.5M | 2.4M |
| Mastercard Incorporated | MA | Shares | $217.4M | 435K |
| Mckesson Corp | MCK | Shares | $202.8M | 234K |
| Agios Pharmaceuticals Inc | AGIO | Shares | $192.3M | 5.7M |
| Centessa Pharmaceuticals Plc | 260 | Shares | $191.0M | 4.8M |
| Tango Therapeutics Inc | TNGX | Shares | $190.3M | 9.1M |
| Grail Inc | GRAL | Shares | $168.2M | 3.3M |
| Tyra Biosciences Inc | TYRA | Shares | $137.1M | 3.6M |
| Tenet Healthcare Corp | THC | Shares | $85.3M | 452K |
| Cardinal Health Inc | CAH | Shares | $77.8M | 368K |
| Vaxcyte Inc | PCVX | Shares | $73.3M | 1.3M |
| Dianthus Therapeutics Inc | DNTH | Shares | $70.2M | 836K |
| Brightspring Health Svcs Inc | BTSG | Shares | $68.9M | 1.6M |
| Twist Bioscience Corp | TWST | Shares | $67.8M | 1.4M |
| Baidu Inc | BIDU | Shares | $49.4M | 444K |
| Cg Oncology Inc | CGON | Shares | $45.6M | 674K |
| Astrazeneca Plc | Shares | $44.7M | 226K | |
| Vnet Group Inc | VNET 2 10/01/27 | Principal | $44.5M | 45.0M |
| Merck & Co Inc | MRK | Shares | $43.4M | 361K |
| Acadia Healthcare Company In | ACHC | Shares | $40.6M | 1.7M |
| Welltower Inc | WELL | Shares | $39.5M | 200K |
| Immunovant Inc | IMVT | Shares | $38.4M | 1.5M |
| Enanta Pharmaceuticals Inc | ENTA | Shares | $36.3M | 2.9M |
| Johnson & Johnson | JNJ | Shares | $36.2M | 148K |
| Beta Bionics Inc | BBNX | Shares | $36.2M | 3.6M |
| Assembly Biosciences Inc | ASMB | Shares | $34.1M | 1.2M |
| Joyy Inc | JOYY | Shares | $33.8M | 578K |
| Strategy Inc | MSTR 0 12/01/29 | Principal | $32.9M | 39.5M |
| Netease Com Inc | NTES | Shares | $32.6M | 291K |
| Novo-Nordisk A S | NVO | Shares | $28.7M | 782K |
| Bitwise 10 Crypto Index Etf | BITW | Shares | $26.9M | 603K |
| Perceptive Cap Solutions Cor | Shares | $24.7M | 2.3M | |
| Royalty Pharma Plc | Shares | $23.6M | 493K | |
| Minerva Neurosciences Inc | NERV | Shares | $14.2M | 2.4M |
| Ceco Environmental Corp | CECO | Shares | $13.9M | 234K |
| Avalo Therapeutics Inc | AVTX | Shares | $13.7M | 916K |
| Cg Oncology Inc | Call | $13.5M | 200K | |
| Gds Hldgs Ltd | GDS | Shares | $11.8M | 292K |
| Maze Therapeutics Inc | MAZE | Shares | $11.1M | 373K |
| Teva Pharmaceutical Inds Ltd | TEVA | Shares | $10.7M | 354K |
| Formfactor Inc | FORM | Shares | $5.5M | 57K |
| Mastec Inc | MTZ | Shares | $5.5M | 17K |
| Entegris Inc | ENTG | Shares | $5.3M | 46K |
| Citigroup Inc | C | Shares | $5.3M | 47K |
| Vnet Group Inc | VNET | Shares | $5.2M | 623K |
| Hyatt Hotels Corp | H | Shares | $5.2M | 36K |
| Western Alliance Bancorp | WAL | Shares | $5.2M | 73K |
| Timken Co | TKR | Shares | $5.1M | 51K |
| Flextronics Intl Ltd | Shares | $5.1M | 78K | |
| S&P Global Inc | SPGI | Shares | $5.1M | 12K |
| Littelfuse Inc | LFUS | Shares | $5.1M | 15K |
| Piper Sandler Companies | PIPR | Shares | $5.1M | 66K |
| Aar Corp | AIR | Shares | $5.0M | 46K |
| Rio Tinto Plc | RIO | Shares | $5.0M | 54K |
| Garrett Motion Inc | GTX | Shares | $5.0M | 275K |
| Rollins Inc | ROL | Shares | $5.0M | 93K |
| Affirm Hldgs Inc | AFRM | Shares | $4.9M | 108K |
| Inter & Co Inc | Shares | $4.9M | 615K | |
| Cummins Inc | CMI | Shares | $4.8M | 9K |
| Fiserv Inc | FISV | Shares | $4.8M | 86K |
| Vertiv Holdings Co | VRT | Shares | $4.8M | 19K |
| Amkor Technology Inc | AMKR | Shares | $4.7M | 104K |
| Atrium Therapeutics Inc | RNA | Shares | $4.7M | 349K |
| Globalfoundries Inc | Shares | $4.7M | 105K | |
| Molina Healthcare Inc | MOH | Shares | $4.7M | 35K |
| Opus Genetics Inc | IRD | Shares | $4.5M | 1.0M |
| Tenable Hldgs Inc | TENB | Shares | $4.5M | 265K |
| Prime Medicine Inc | PRME | Shares | $4.3M | 1.2M |
| Servicenow Inc | NOW | Shares | $4.3M | 41K |
| Summit Midstream Corporation | SMC | Shares | $1.8M | 58K |
| Madrigal Pharmaceuticals Inc | MDGL | Shares | $1.7M | 3K |
| Capricor Therapeutics Inc | CAPR | Shares | $1.2M | 41K |
| Arrowhead Pharmaceuticals In | ARWR | Shares | $991K | 16K |
| Aleanna Inc | ANNAW | Shares | $802K | 990K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.